AT rich interactive domain 1A (ARID1A); ARID1B; breast cancer 1 early onset (BRCA1); BRCA2; K-Ras (KRAS); phosphoinositide 3-kinase (PI3K) BriefCommunication Pages: 1201 - 1201
Lymphotoxin-α (LTα); lymphotoxin-β receptor (LTBR); chemokine CXC motif ligand 13 (CXCL13); CXC chemokine receptor 5 (CXCR5) BriefCommunication Pages: 1204 - 1204
Neurokinin 3 receptor (TACR3; NK3R); gonadotropin-releasing hormone (GnRH) BriefCommunication Pages: 1209 - 1209
Genetically defined triple-knockout mouse model of high-grade superficial bladder cancer BriefCommunication Pages: 1213 - 1213
Nonhuman primate model of β-amyloid (Aβ)-induced Alzheimer's disease (AD) BriefCommunication Pages: 1214 - 1214
Cytosolic delivery of antibody mimics using anthrax toxin protective antigen (PA) and the N-terminal domain (LFN) of the anthrax toxin lethal factor (LF) BriefCommunication Pages: 1215 - 1215
Hydrogel delivery system for controlled delivery of bupivacaine BriefCommunication Pages: 1216 - 1216
Clustered, regularly interspaced short palindromic repeats (CRISPR)-Cas9 genome editing for designing antibiotic, RNA-guided nucleases BriefCommunication Pages: 1217 - 1217
DEP domain containing 6 (DEPTOR; DEPDC6) inhibition to enhance differentiation of embryonic stem (ES) cells BriefCommunication Pages: 1218 - 1218
Prevention of immunogenicity to therapeutic proteins by co-treatment with O-phospho-l-serine (OPLS) BriefCommunication Pages: 1219 - 1219
Dual-modality immuno–single-photon emission computed tomography (immuno-SPECT) and near-infrared fluorescence (NIRF) imaging probes to guide prostate cancer surgery BriefCommunication Pages: 1220 - 1220
Seven-antibody composite biomarker panel to predict recurrent focal segmental glomerulosclerosis (rFSGS) after kidney transplantation BriefCommunication Pages: 1221 - 1221
Single-cell immune signatures from mass cytometry to predict clinical recovery from surgery BriefCommunication Pages: 1222 - 1222